biblioteca virtual en salud

BVS - Literatura Cientifica y Técnica

 

Historico de búsqueda  ()

Su selección  ()

Collapse All  Ocultar
Expand All  Mostrar
Tipo
Texto completo (58033)
Idioma
Año
Resultados  1-10 de 104.484
Enviar resultado
adicionar en sua lista
1.

Evaluación de Tecnologías Sanitarias (ETESA) una visión global del concepto y de sus alcances/ Health Technology Assessment (HTA). An overview of the concept and its scope

Manterola, Carlos; Otzen, Tamara; Castro, Mayra; Grande, Luis
| Idioma(s): Español
La progresivas preocupación de los países para optimizar el acceso, la eficiencia y la calidad de la salud, han impulsado la utilización más apropiada de las intervenciones en salud. Por ende, el interés tanto de profesionales sanitarios como de tomadores de decisiones en salud, ha sido orientado hacia la medicina basada en la evidencia, la eficacia comparativa y la Evaluación de Tecnologías Sanitarias (ETESA). Aunque los conceptos anteriormente señalados son convergentes en sus características, no son sinónimos. Sin embargo, todos estos, se basan en la orientación sistemática de pruebas y el enfoque en resultados relevantes para el paciente entre otras. Como consecuencia de todo esto, el interés no sólo implica los conceptos de eficacia, efectividad y eficiencia; sino que también en práctica clínica, costes y transparencia. En este artículo se resumen los conceptos de economía de la salud, evaluación económica, tecnología sanitaria (TS) y ETESA. Luego, se comenta el ciclo de vida de una TS, razones para implementar un programa de ETESA; para finalizar con algunos ejemplos de TS emergentes, comentarios respecto de la evidencia científica en la ETESA; y algunos ejemplos de estudios de ETESA en la práctica clínica cotidiana. The progressive concern of countries to optimize access, efficiency and quality of health have led to the most appropriate use of health interventions. Therefore, the interest of both health professionals and health decision makers has been oriented towards evidence-based policy, comparative efficacy and Health Technologies Assessment (HTA). Although the aforementioned concepts are converging in their characteristics, they are not synonymous. However, all these are based on systematic testing orientation and focus on relevant patient outcomes among others. As a consequence of all this, interest does not only imply the concepts of effectiveness, effectiveness and efficiency, but also in clinical practice, costs and transparency.This manuscript summarizes concepts of health economics, economic evaluation, health technology and HTA. Then, the life cycle of a health technology and the reasons for implementing an HTA program are discussed. Concluding with some examples of emerging health technologies, comments on the scientific evidence in HTA, and some examples of HTA studies in daily clinical practice.
adicionar en sua lista
2.

The rising health, social and economic costs of Australia's ageing prisoner population.

Ginnivan, Natasha A; Butler, Tony G; Withall, Adrienne N
| Idioma(s): Inglés
adicionar en sua lista
3.

Socio-economic differentials in minimum dietary diversity among young children in South-East Asia: evidence from Demographic and Health Surveys.

Harvey, Chloe M; Newell, Marie-Louise; Padmadas, Sabu S
| Idioma(s): Inglés
OBJECTIVE: To investigate the socio-economic differentials underlying minimum dietary diversity (MDD) among children aged 6-23 months in three economically diverse South-East Asian countries. DESIGN: The outcome variable MDD was defined as the proportion of children aged 6-23 months who received foods from four of the seven recommended food groups within the 24 h prior to interview. The association between socio-economic factors and MDD, adjusting for relevant characteristics, was examined using logistic regression. SETTING: We used cross-sectional population data from recent Demographic and Health Surveys from Cambodia (2014), Myanmar (2015-16) and Indonesia (2012). SUBJECTS: Total of 8364 children aged 6-23 months. RESULTS: Approximately half of all children met the MDD, varying from 47·7 % in Cambodia (n 1023) to 58·2 % in Indonesia (n 2907) and 24·6 % in Myanmar (n 301). The likelihood (adjusted OR; 95 % CI) of meeting MDD increased for children in the richest households (Cambodia: 2·4; 1·7, 3·4; Myanmar: 1·8; 1·1, 3·0; Indonesia: 2·0; 1·6, 2·5) and those residing in urban areas (Cambodia: 1·4; 1·1, 1·9; Myanmar: 1·7; 1·2, 2·4; Indonesia: 1·7; 1·5, 1·9). MDD deprivation was most severe among children from the poorest households in rural areas. The association between mother's labour force participation and MDD was positive in all three countries but reached significance only in Indonesia (1·3; 1·1, 1·5). CONCLUSIONS: MDD deprivation among young children was significantly high in socio-economically disadvantaged families in all three study settings. MDD requirements are not being met for approximately half of young children in these three South-East Asian countries.
adicionar en sua lista
9.

Health-related quality of life, work productivity, and economic burden among patients with Parkinson's disease in Japan.

Yamabe, Kaoru; Liebert, Ryan; Flores, Natalia; Pashos, Chris
| Idioma(s): Inglés
AIMS: This study aimed to characterize the burden of Parkinson's disease (PD) by examining health-related quality of life (HRQoL), impairments to work productivity and daily activities, healthcare resource use, and associated costs among Japanese patients with PD. MATERIALS AND METHODS: This retrospective cross-sectional study used data from the 2009-2014 Japan National Health and Wellness Survey (NHWS) (N = 144,692). HRQoL (Short Form 36-Item Health Survey version 2), impairments to work productivity and daily activities (Work Productivity and Activity Impairment Questionnaire), healthcare resource utilization, and annual costs were compared between respondents with PD (n = 133) and controls without PD (n = 144,559). The effect of PD on outcomes was estimated using propensity score weighting and multivariable regression models. RESULTS: HRQoL was lower in patients with PD compared to the control group, with reduced physical (41.3 vs. 51.3) and mental (35.7 vs. 45.4) component summary scores and health state utility scores (0.6 vs. 0.7; P<0.001 for all). Patients with PD also reported higher levels of absenteeism (19.39 vs. 3.3%), presenteeism (45.2% vs. 18.5%), overall work impairment (52.8% vs. 20.3%), and activity impairment (49.6% vs. 20.8%) than controls without PD (P<0.001 for all). In addition, patients with PD had higher healthcare resource utilization, direct (¥3,856,921/$37,994 vs. ¥715,289/$7,046), and indirect (¥2,573,938/$25,356 vs. ¥902,534/$8,891) costs compared with controls without PD (P<0.001 for both). LIMITATIONS: Data were cross-sectional and did not allow for causal inferences. Although the NHWS demographically represents the Japanese adult population, it is unclear whether it adequately represents the adult population with PD in Japan. CONCLUSIONS: PD was associated with poorer HRQoL, greater work productivity loss, and higher direct and indirect costs. The findings suggest that an unmet need exists among patients with PD in Japan. Improving PD treatment and management could benefit both patients and society.
Resultados  1-10 de 104.484